Karyopharm Therapeutics Inc. - 8-K Filing
Karyopharm Therapeutics issued $20M worth of new preferred stock to satisfy fees under a Forbearance Agreement (Items: 3.03 Material Modification to Rights of Security Holders, 5.03 regarding the Certificate of Designations is incorporated into this Item 3, 9.01 Financial Statements and Exhibits)
Tickers: $KPTI